Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
Completed
Conditions studied: Heart Failure
In brief
To learn in a general Cardiac Resynchronization Therapy Defibrillators (CRT-D) population, which optimization techniques are used and how effective they are. It will compare 12-month response rates among different optimization methods and characterize which selected subject subgroups achieve better response than others. A subset of SMART Registry subjects will contribute to the NG4 Post Market Clinical Follow Up (PMCF) Cohort whose objective is collecting data on the NG4 CRT-D features and device usage in a real world setting and monitor long term safety associated with these devices to support CE Mark.
Key facts
- Study ID
- NCT03075215
- Run by
- Boston Scientific Corporation
- People needed
- 2044
- Starts
- 2017-04-14
- Expected to finish
- 2021-11-15
- Last updated by the study team
- 2023-10-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject implanted or upgraded with a NG3 or NG4 CRT-D device connected with any manufacturer quadripolar LV lead based on BSC labeling for devices in specific geographies.
- Subjects must be enrolled between 1 and 21 calendar days post CRT-D implantation procedure.
- Subject is age 18 or above, or of legal age to give informed consent specific to each country and national laws
- Subject is willing and capable of complying with follow-up visits and procedures as defined by this protocol
You may not qualify if…
- Subject with documented life expectancy of less than 12 months
- Subject currently on the active heart transplant list or has a current Left Ventricular Assist Device or other assist device (mechanical circulatory support device).
- Subject who have had a pre-existing CRT device
- Subject enrolled in any other concurrent clinical trial without prior written approval from BSC Clinical Trial Manager
- Women of childbearing potential who are or might be pregnant at time of study enrolment
- Any contra-indication to receive a CRT-D device per local guidelines
Where it is running
- CardioVascular Associates of Mesa — Mesa, Arizona, United States
- Arrhythmia Research Group — Jonesboro, Arkansas, United States
- Comprehensive Cardiovascular Medical Group — Bakersfield, California, United States
- VA Loma Linda Healthcare System — Loma Linda, California, United States
- Western Connecticut Health Network/ Danbury Hospital — Danbury, Connecticut, United States
- Bay Area Cardiology Associates, P.A. — Brandon, Florida, United States
- North Florida/South Georgia Veterans Health System — Gainesville, Florida, United States
- Northeast Georgia Heart Center — Gainesville, Georgia, United States
- The University of Illinois Medical Center — Chicago, Illinois, United States
- Riverside Medical Center / Midwest Arrhythmia Consultants — Kankakee, Illinois, United States
- Ball Memorial Hospital — Muncie, Indiana, United States
- Midwest Cardiovascular Research Foundation — Davenport, Iowa, United States
- Cardiovascular Institute of the South — Lafayette, Louisiana, United States
- Sinai Hospital of Baltimore — Baltimore, Maryland, United States
- Peninsula Cardiology Associates — Salisbury, Maryland, United States
- Hurley Medical Center — Flint, Michigan, United States
- Summit Medical Group, P.A. — Berkeley Heights, New Jersey, United States
- Trinity Medical WNY,PC — Buffalo, New York, United States
- Columbia. University Medical Center/ NY Presbyterian Hospital — New York, New York, United States
- New Hanover Regional Medical Center — Wilmington, North Carolina, United States
- St. Alexius Medical Center — Bismarck, North Dakota, United States
- Kettering Medical Center — Kettering, Ohio, United States
- Abington Memorial Hospital — Abington, Pennsylvania, United States
- Regional Cardiac Arrythmia — Washington, Pennsylvania, United States
- Providence Alaska Medical Center — Anchorage, Alaska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.